We found proliferation was not significantly different in control CD34+ cells in comparison to CD34+ CML cells with DN-Gas2 plus IM (p>0.04, n=3 for all three cytokine doses). The gene discussed is GAS2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.